Neeser J R, Granato D, Rouvet M, Servin A, Teneberg S, Karlsson K A
Nestlé Research Center, Vers-chez-les-Blanc, CH-1000 Lausanne 26, Switzerland.
Glycobiology. 2000 Nov;10(11):1193-9. doi: 10.1093/glycob/10.11.1193.
The carbohydrate-binding specificities of the probiotic lactic acid bacterium Lactobacillus johnsonii La1 (a health-beneficial bacterial strain able to be incorporated into the human intestinal microflora) were investigated in vitro. First various soluble complex carbohydrates were tested as potential inhibitors of the strain adhesion onto Caco-2 intestinal epithelial cells, and then bacterial binding to glycolipids immobilized on TLC plates was probed. Two major carbohydrate-binding specificities of Lactobacillus johnsonii La1 were identified. A first one for an Endo-H treated yeast cell wall mannoprotein carrying mainly O:-linked oligomannosides, and a second one for the gangliotri- and gangliotetra-osylceramides (asialo-GM1). Similar carbohydrate-binding specificities are known to be expressed on cell surface adhesins of several enteropathogens, enabling them to adhere to the host gut mucosa. These findings corroborate the hypothesis that selected probiotic bacterial strains could be able to compete with enteropathogens for the same carbohydrate receptors in the gut.
对益生菌约氏乳杆菌La1(一种能够整合到人体肠道微生物群中的有益健康的细菌菌株)的碳水化合物结合特异性进行了体外研究。首先,测试了各种可溶性复合碳水化合物作为该菌株黏附到Caco-2肠上皮细胞上的潜在抑制剂,然后检测了细菌与固定在薄层层析板上的糖脂的结合情况。确定了约氏乳杆菌La1的两种主要碳水化合物结合特异性。第一种是针对主要携带O-连接寡甘露糖的内切糖苷酶H处理的酵母细胞壁甘露糖蛋白,第二种是针对神经节三糖和神经节四糖神经酰胺(脱唾液酸GM1)。已知几种肠道病原体的细胞表面黏附素也表达类似的碳水化合物结合特异性,使它们能够黏附到宿主肠道黏膜上。这些发现证实了以下假设:选定的益生菌菌株能够在肠道中与肠道病原体竞争相同的碳水化合物受体。